AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

What symbol and exchange does Anaptysbio shares trade?

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

What is Anaptysbio stock price doing today?

As of November 11, 2026, ANAB stock price climbed to $48.82 with 36,468 million shares trading.

What is Anaptysbio's Beta?

ANAB has a beta of 0.74, meaning it tends to be less sensitive to market movements. ANAB has a correlation of 0.01 to the broad based SPY ETF.

How much is Anaptysbio worth?

ANAB has a market cap of $1.46 billion. This is considered a Small Cap stock.

How much money does Anaptysbio make?

Last quarter Anaptysbio reported $27 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.35.

What is the highest and lowest price Anaptysbio traded in the last 3 year period?

In the last 3 years, ANAB traded as high as $72.36 and as low as $6.11.

What are the top ETFs holding Anaptysbio?

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

Is Anaptysbio (ANAB) a good investment?

ANAB has outperformed the market in the last year with a return of +187.3%, while the SPY ETF gained +12.5%. However, in the most recent history, ANAB shares have underperformed the stock market with its stock returning -12.0% in the last 3 month period and -1.6% for the last 2 week period, while SPY has returned -1.6% and -1.4%, respectively.

What are the support and resistance levels for Anaptysbio (ANAB)?

ANAB support price is $46.65 and resistance is $50.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB shares will trade within this expected range on the day.